BioCentury
ARTICLE | Company News

Management tracks: GSK, J&J, Denali

August 7, 2018 7:09 PM UTC

GlaxoSmithKline plc (NYSE:GSK; LSE:GSK) hired Iain Mackay as CFO and executive director. Mackay, who is group finance director at HSBC, will join GSK on Jan. 14, 2019 as CFO designate and take formal accountability as CFO on April 1, 2019. In May, the pharma announced that CFO Simon Dingemans is to retire in May 2019.

Johnson & Johnson (NYSE:JNJ) hired Michal Preminger as head of Johnson & Johnson Innovation Boston. She was executive director at Harvard University’s Office of Technology Development Harvard Medical School site. At Harvard, Preminger negotiated agreements with biopharma and life sciences companies to translate discoveries from the medical school's laboratories into revenue-generating products, and worked with scientific founders and investors to create new startups...